Fund Holdings — NEA Management Company, LLC

Total Portfolio Value:
$1.96B
Total Bought:
$322.76M
Total Sold:
$266.66M
Net Transaction:
+$56.10M
Notable People:
Anthony Angelo Florence, Mohamad Hassan Makhzoumi
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Celcuity Inc.(CELC)2,144,2613,535,561+1,391,300$105.93M$352.64M17.98%+$246.71M
Rhythm Pharmaceuticals, Inc.(RYTM)2,909,9562,909,9560$293.88M$311.48M15.88%+$17.61M
Arcellx, Inc.
COMMON STOCK
3,045,2623,045,2620$250.02M$198.55M10.12%-$51.46M
Trevi Therapeutics, Inc.(TRVI)13,222,22813,222,2280$120.98M$165.54M8.44%+$44.56M
Savara Inc.(SVRA)24,471,26424,471,2640$87.36M$147.56M7.52%+$60.20M
Zenas BioPharma, Inc.(ZBIO)2,733,7193,523,219+789,500$60.69M$127.93M6.52%+$67.24M
Monte Rosa Therapeutics, Inc.(GLUE)7,692,2987,692,2980$57.00M$120.62M6.15%+$63.62M
MBX Biosciences, Inc.(MBX)3,614,4863,614,4860$63.25M$114.00M5.81%+$50.75M
Coursera, Inc.(COUR)12,867,76912,867,7690$150.68M$94.71M4.83%-$55.97M
Aurinia Pharmaceuticals Inc.(AUPH)3,969,8343,969,8340$43.87M$63.32M3.23%+$19.45M
Gossamer Bio, Inc.(GOSS)18,093,03418,093,0340$47.58M$56.09M2.86%+$8.50M
CRISPR Therapeutics AGNAMEN AKT(CRSP)1,058,5701,058,5700$68.61M$55.51M2.83%-$13.09M
ORIC Pharmaceuticals, Inc.(ORIC)4,118,6214,118,6210$49.42M$33.69M1.72%-$15.73M
Phathom Pharmaceuticals, Inc.(PHAT)1,960,1691,960,1690$23.07M$32.52M1.66%+$9.45M
CVRx, Inc.(CVRX)2,026,0832,026,0830$16.35M$14.39M0.73%-$1.97M
X4 Pharmaceuticals, Inc.(XFOR)2,233,7433,233,743+1,000,000$7.64M$12.93M0.66%+$5.30M
Champions Oncology, Inc.(CSBR)1,713,7201,713,7200$11.10M$11.84M0.60%+$745.5K
Black Diamond Therapeutics, Inc.4,448,7574,448,7570$16.86M$10.81M0.55%-$6.05M
Korro Bio, Inc.(KRRO)1,090,7931,090,7930$52.24M$8.74M0.45%-$43.50M
Inventiva S.A.ADS(IVA)1,462,5861,462,5860$8.32M$6.80M0.35%-$1.52M
Nkarta, Inc.(NKTX)3,568,7813,568,7810$7.39M$6.60M0.34%-$785.1K
Senti Biosciences, Inc.
COM NEW
3,775,6153,775,6150$5.32M$3.93M0.20%-$1.40M
LeonaBio, Inc.(LONA)0464,398+464,398$0$3.52M0.18%+$3.52M
Synlogic, Inc.(SYBX)2,922,7722,922,7720$4.88M$3.27M0.17%-$1.60M
Marker Therapeutics, Inc.(MRKR)1,625,6781,625,6780$1.45M$2.42M0.12%+$971.2K
OnKure Therapeutics, Inc.CL A(OKUR)478,548478,5480$1.32M$1.39M0.07%+$71.8K
ImageneBio, Inc.(IMA)50,00550,0050$407.5K$345.0K0.02%-$62.5K
Neuehealth Inc2,726,9170-2,726,917$18.19M$0—-$18.19M
Omada Health, Inc.(OMDA)364,1150-364,115$8.05M$0—-$8.05M
Verona Pharma PlcADS2,252,9940-2,252,994$240.42M$0—-$240.42M
Page 1 of 1
NEA Management Company, LLC — 13F Holdings — Q4 2025 | TickerTrail